PHOSPHODIESTERASE-5 INHIBITOR USE AND PROGRESSION TO HEART FAILURE IN MEN WITH CORONARY ARTERY DISEASE AND ERECTILE DYSFUNCTION

被引：0
|
作者：
Ha, A. [1 ]
Wayne, G. [2 ]
Jacobs, M. [3 ]
Kalogeropoulos, A. [3 ]
Alukal, J. [2 ]
机构：
[1] Columbia Univ Irving Med Ctr, New York, NY USA
[2] Columbia Univ Irving Med Ctr, Dept Urol, New York, NY USA
[3] Stony Brook Univ Hosp, Div Cardiol, Stony Brook, NY USA
来源：
JOURNAL OF SEXUAL MEDICINE | 2023年 / 20卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
203
引用
收藏
页数：2
相关论文
共 50 条
  • [1] PHOSPHODIESTERASE-5 INHIBITOR USE AND PROGRESSION TO HEART FAILURE IN MEN WITH CORONARY ARTERY DISEASE AND ERECTILE DYSFUNCTION
    Ha, Albert
    Wayne, George
    Jacobs, Mark
    Kalogeropoulos, Andreas
    Alukal, Joseph
    JOURNAL OF UROLOGY, 2023, 209 : E336 - E336
  • [2] ASSESSMENT OF HEADACHE IN MEN TAKING PHOSPHODIESTERASE-5 INHIBITOR (TADALAFIL) FOR ERECTILE DYSFUNCTION
    Okuyucu, E. Esra
    Guven, Oguz
    Ucar, Edip
    Duman, Taskin
    ACTA MEDICA MEDITERRANEA, 2014, 30 (05): : 1007 - 1011
  • [3] Phosphodiesterase-5 Inhibitors in Men With Stable Coronary Artery Disease
    Wen, Zhili
    Feng, Yuliang
    Jiang, Lei
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 78 (03) : 294 - 295
  • [4] Phosphodiesterase-5 Inhibitors and Survival in Men With Coronary Artery Disease
    Maas, Renke
    Rodionov, Roman N.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2021, 77 (12) : 1551 - 1553
  • [5] Vardenafil: a selective inhibitor of phosphodiesterase-5 for the treatment of erectile dysfunction
    Reffelmann, Thorsten
    Kloner, Robert A.
    EXPERT OPINION ON PHARMACOTHERAPY, 2007, 8 (07) : 965 - 974
  • [6] The effect of vardenafil, a potent and highly selective phosphodiesterase-5 inhibitor for the treatment of erectile dysfunction, on the cardiovascular response to exercise in patients with coronary artery disease
    Thadani, U
    Smith, W
    Nash, S
    Bittar, N
    Glasser, S
    Narayan, P
    Stein, RA
    Larkin, S
    Mazzu, A
    Tota, R
    Pomerantz, K
    Sundaresan, P
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 40 (11) : 2006 - 2012
  • [7] Phosphodiesterase-5 inhibitors: erectile quality and emotional correlates in men with erectile dysfunction and their partners
    Gutierrez Hernandez, Pedro Ramon
    Cabello Santamaria, Francisco
    Moncada Iribarren, Ignacio
    REVISTA INTERNACIONAL DE ANDROLOGIA, 2010, 8 (04): : 155 - 164
  • [8] Avanafil, a Potent and Highly Selective Phosphodiesterase-5 Inhibitor for Erectile Dysfunction
    Kotera, Jun
    Mochida, Hideki
    Inoue, Hirotaka
    Noto, Tsunehisa
    Fujishige, Kotomi
    Sasaki, Takashi
    Kobayashi, Tamaki
    Kojima, Koki
    Yee, Shiyin
    Yamada, Yasuhiro
    Kikkawa, Kohei
    Omori, Kenji
    JOURNAL OF UROLOGY, 2012, 188 (02): : 668 - 674
  • [9] Phosphodiesterase-5 inhibitors use in patients with erectile dysfunction and cardiovascular disease in clinical practice
    Mamedov, M. N.
    Sharvadze, G. G.
    Poddubsky, E. A.
    Ausheva, A. K.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2010, 6 (05) : 691 - 696
  • [10] Phosphodiesterase-5 inhibitors for male erectile dysfunction
    Sui, ZH
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2003, 13 (09) : 1373 - 1388
12345